IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab Altorki, N., Felip, E., Zhou, C., Vallieres, E., Moiseyenko, V., Smolin, A., Rittmeyer, A., Vereshchako, R., Perol, M., Schutte, W., Fang, J., Tao, M., Teixeira, E., Kim, Y., Gitlitz, B., Bennett, E., Mcnally, V., Wu, F., Deng, Y., Wakelee, H. ELSEVIER SCIENCE INC. 2021: S845-S846

View details for Web of Science ID 000709606500030